Trial Details
RECRUITINGBasic Information
| Clinical ID | c714 |
|---|---|
| Identifier | NCT06180382 |
| Trial Title | Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Adalimumab|DRUG: Vedolizumab |
Participant Information
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
|---|---|
| City | Paris |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-10-31 |
|---|---|
| Primary Completion Date | 2026-01 |
| Completion Date | 2027-01 |